Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the access of the population to innovative medical treatment and quality health services. This was propelled by active government policies directed towards scientific knowledge generation and technology adoption, alignment of the regulation with the best international practices, and infrastructure enhancements in all stages of the healthcare process – from prevention and treatment to rehabilitation and palliative care. Private capitals also played a role, supported by the opening of the pharma and healthcare markets to foreign investors in most countries and the liberalisation of foreign trade in raw inputs, pharmaceuticals and medical devices. From the demand side, the ageing of the population and the rapid shift towards the epidemiological profile of developed countries have resulted in an increasing demand for complex medical treatment, innovative drugs and vaccines.

01 REGIONAL OVERVIEW 

02 BRAZIL 

03 MEXICO 

04 ARGENTINA 

05 COLOMBIA 

06 CHILE 

07 PERU